Avoid NuvaRing for Women at High Risk of Clotting

Updates to labelling will bring questions about the risk of thrombosis with NuvaRing.

We know that combined hormonal contraceptives increase the risk of blood clots.

But now women are hearing that the risk may be higher with NuvaRing than with combined OCs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote